Copyright Reports & Markets. All rights reserved.

Global Recombinant Human Erythropoietin (rhEPO) Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Recombinant Human Erythropoietin (rhEPO) Market Overview

      • 1.1 Product Overview and Scope of Recombinant Human Erythropoietin (rhEPO)
      • 1.2 Recombinant Human Erythropoietin (rhEPO) Segment by Type
        • 1.2.1 Global Recombinant Human Erythropoietin (rhEPO) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 ESRD
        • 1.2.3 Cancer
        • 1.2.4 HIV
        • 1.2.5 Wounds and neural disease
      • 1.3 Recombinant Human Erythropoietin (rhEPO) Segment by Application
        • 1.3.1 Recombinant Human Erythropoietin (rhEPO) Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Retail Pharmacies
      • 1.4 Global Recombinant Human Erythropoietin (rhEPO) Market by Region
        • 1.4.1 Global Recombinant Human Erythropoietin (rhEPO) Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Recombinant Human Erythropoietin (rhEPO) Market Size
        • 1.5.1 Global Recombinant Human Erythropoietin (rhEPO) Revenue (2014-2025)
        • 1.5.2 Global Recombinant Human Erythropoietin (rhEPO) Production (2014-2025)

      2 Global Recombinant Human Erythropoietin (rhEPO) Market Competition by Manufacturers

      • 2.1 Global Recombinant Human Erythropoietin (rhEPO) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Recombinant Human Erythropoietin (rhEPO) Production Sites, Area Served, Product Types
      • 2.5 Recombinant Human Erythropoietin (rhEPO) Market Competitive Situation and Trends
        • 2.5.1 Recombinant Human Erythropoietin (rhEPO) Market Concentration Rate
        • 2.5.2 Recombinant Human Erythropoietin (rhEPO) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Recombinant Human Erythropoietin (rhEPO) Production Market Share by Regions

      • 3.1 Global Recombinant Human Erythropoietin (rhEPO) Production Market Share by Regions
      • 3.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Recombinant Human Erythropoietin (rhEPO) Production
        • 3.4.1 North America Recombinant Human Erythropoietin (rhEPO) Production Growth Rate (2014-2019)
        • 3.4.2 North America Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Recombinant Human Erythropoietin (rhEPO) Production
        • 3.5.1 Europe Recombinant Human Erythropoietin (rhEPO) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Recombinant Human Erythropoietin (rhEPO) Production (2014-2019)
        • 3.6.1 China Recombinant Human Erythropoietin (rhEPO) Production Growth Rate (2014-2019)
        • 3.6.2 China Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Recombinant Human Erythropoietin (rhEPO) Production (2014-2019)
        • 3.7.1 Japan Recombinant Human Erythropoietin (rhEPO) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Recombinant Human Erythropoietin (rhEPO) Consumption by Regions

      • 4.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption by Regions
      • 4.2 North America Recombinant Human Erythropoietin (rhEPO) Consumption (2014-2019)
      • 4.3 Europe Recombinant Human Erythropoietin (rhEPO) Consumption (2014-2019)
      • 4.4 China Recombinant Human Erythropoietin (rhEPO) Consumption (2014-2019)
      • 4.5 Japan Recombinant Human Erythropoietin (rhEPO) Consumption (2014-2019)

      5 Global Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price Trend by Type

      • 5.1 Global Recombinant Human Erythropoietin (rhEPO) Production Market Share by Type (2014-2019)
      • 5.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Recombinant Human Erythropoietin (rhEPO) Price by Type (2014-2019)
      • 5.4 Global Recombinant Human Erythropoietin (rhEPO) Production Growth by Type (2014-2019)

      6 Global Recombinant Human Erythropoietin (rhEPO) Market Analysis by Applications

      • 6.1 Global Recombinant Human Erythropoietin (rhEPO) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Recombinant Human Erythropoietin (rhEPO) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Recombinant Human Erythropoietin (rhEPO) Business

      • 7.1 3SBio
        • 7.1.1 3SBio Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.1.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Shanghai Chemo
        • 7.2.1 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.2.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Chengdu Diao
        • 7.3.1 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.3.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.3.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 NCPC Genetech
        • 7.4.1 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.4.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Kyowa Hakko Kirin
        • 7.5.1 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.5.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Shandong Kexing
        • 7.6.1 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.6.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Ahua Pharmaceutical
        • 7.7.1 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.7.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.7.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Biosidus
        • 7.8.1 Biosidus Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.8.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Dragon Pharma
        • 7.9.1 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Production Sites and Area Served
        • 7.9.2 Recombinant Human Erythropoietin (rhEPO) Product Introduction, Application and Specification
        • 7.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Recombinant Human Erythropoietin (rhEPO) Manufacturing Cost Analysis

      • 8.1 Recombinant Human Erythropoietin (rhEPO) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Recombinant Human Erythropoietin (rhEPO)
      • 8.4 Recombinant Human Erythropoietin (rhEPO) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Recombinant Human Erythropoietin (rhEPO) Distributors List
      • 9.3 Recombinant Human Erythropoietin (rhEPO) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Recombinant Human Erythropoietin (rhEPO) Market Forecast

      • 11.1 Global Recombinant Human Erythropoietin (rhEPO) Production, Revenue Forecast
        • 11.1.1 Global Recombinant Human Erythropoietin (rhEPO) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Recombinant Human Erythropoietin (rhEPO) Price and Trend Forecast (2019-2025)
      • 11.2 Global Recombinant Human Erythropoietin (rhEPO) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Recombinant Human Erythropoietin (rhEPO) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Recombinant Human Erythropoietin (rhEPO) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Recombinant Human Erythropoietin (rhEPO) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Recombinant Human Erythropoietin (rhEPO) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Recombinant Human Erythropoietin (rhEPO) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2019-2025)
        • 11.3.3 China Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Recombinant Human Erythropoietin (rhEPO) Consumption Forecast (2019-2025)
      • 11.4 Global Recombinant Human Erythropoietin (rhEPO) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Recombinant Human Erythropoietin (rhEPO) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

        The global Recombinant Human Erythropoietin (rhEPO) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Recombinant Human Erythropoietin (rhEPO) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Erythropoietin (rhEPO) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        3SBio
        Shanghai Chemo
        Chengdu Diao
        NCPC Genetech
        Kyowa Hakko Kirin
        Shandong Kexing
        Ahua Pharmaceutical
        Biosidus
        Dragon Pharma

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        ESRD
        Cancer
        HIV
        Wounds and neural disease

        Segment by Application
        Hospitals
        Retail Pharmacies

        Buy now